# Sanyou Bio Secures $15M Series C Funding for AI Drug Discovery

> Sanyou Bio's AI-powered drug discovery platform gains $15 million (RMB 100 million) Series C funding to expand its technology and partnerships.
- Title: Sanyou Bio Secures $15M Series C Funding for AI Drug Discovery
- Summary: Sanyou Bio's AI-powered drug discovery platform gains $15 million (RMB 100 million) Series C funding to expand its technology and partnerships.
- Keywords: sanyou bio, series c funding, ai drug discovery, zero2ipo industry investment, ai-stal, sai-da, clicklinks, pharmaceutical partnerships, Pulse 2.0
- Source: Pulse 2.0 — https://pulse2.com/sanyou-bio-nearly-15-million-rmb-100-million-series-c-funding-expands-ai-powered-drug-discovery-platform
- Author: Amit Chowdhry
- Published: 2026-11-09T20:27:54+00:00
- Read time: 1 min
- Topics: sanyou bio, series c funding, ai drug discovery, zero2ipo industry investment, ai-stal, sai-da, clicklinks, pharmaceutical partnerships, startups, business
## Sanyou Bio Completes Series C Funding
Sanyou Biopharmaceuticals, a Shanghai-based biotechnology company, secured nearly $15 million (RMB 100 million) Series C funding from Zero2IPO Industry Investment.
## Funding Expands AI Drug Discovery Platform
The round supports Sanyou Bio's integrated drug research and development platform, including antibody discovery technology and ai-driven laboratory systems.
## Three Core Technology Platforms
Sanyou Bio's strategy centers on AI-Super-Trillion Antibody Library, Sanyou AI-Drug Accelerator, and Clicklinks for drug discovery.
## AI-Super-Trillion Antibody Library
The AI-STAL platform contains approximately 11 trillion molecular candidates for future therapeutic products.
## Sanyou AI-Drug Accelerator
SAI-DA combines computational drug discovery with wet-laboratory processes to accelerate preclinical research.
## Clicklinks Collaboration Platform
Clicklinks connects pharmaceutical companies, biotech developers, and research partners for collaborative drug discovery projects.
## Global Partnerships and Projects
Sanyou Bio has partnerships with over 2,000 pharmaceutical organizations and more than 100 collaborative research projects worldwide.
## Funding for Future Development
The new funding will support further development of ai technology platforms and clinical translation of drug candidates.
## Key takeaway

Sanyou Bio received $15 million (RMB 100 million) Series C funding from Zero2IPO Industry Investment to advance its AI drug discovery platform.